Hologic Inc
HOLX
View Detailed Chart
63.800USD
-0.650-1.01%
Close 09/15, 16:00（ET）Quotes delayed by 15 min
14.18BMarket Cap
25.45P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.01%
5 Days
-4.12%
1 Month
-5.91%
6 Months
+5.09%
Year to Date
-11.50%
1 Year
-21.38%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-15Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
22
analysts
Buy
Current Rating
73.008
Target Price
+13.28%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Fairly Valued
The company’s latest PE is 26.21, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 230.47M shares, decreasing 5.37% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 26.70M shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Ticker SymbolHOLX
CompanyHologic Inc
CEOMr. Stephen P. (Steve) Macmillan
Websitehttps://www.hologic.com/
Related Instruments
-1.04%
-3.49%
-2.77%
-0.79%
-0.06%
-1.96%
+0.39%
+1.94%
+1.73%
-0.11%
+1.24%
+6.10%
+1.36%
-2.04%
+3.75%
-0.24%
-1.13%
+0.09%
+1.23%
+1.35%
